Petros Pharmaceuticals In... (PTPI)
NASDAQ: PTPI
· Real-Time Price · USD
0.03
-0.00 (-10.18%)
At close: Jun 09, 2025, 3:15 PM
Petros Pharmaceuticals Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 8.93M | 3.71M | 3.89M | 7.46M | 11.08M | 13.34M | 17.97M | 7.38M | 8.32M | 9.43M | 11.18M | 13.3M | 17.67M | 23.85M | 8.14M | 11.03M | 14.57M |
Short-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Assets | 3.14M | n/a | 3M | 3.47M | 3.94M | 4.18M | 4.42M | 4.65M | 4.88M | 5.11M | 5.34M | 5.56M | 4.8M | 11.03M | 11.14M | 11.14M | 11.14M |
Receivables | n/a | 416.08K | 1.95M | 1.78M | 1.96M | 2.23M | 2.98M | 2.58M | 2.4M | 2.11M | 3.73M | 5.75M | 3.74M | 2.46M | 1.95M | 2.02M | 6.19M |
Inventory | n/a | 1.35M | 1.41M | 1.43M | 1.56M | 2.79M | 2.5M | 2.18M | 2.04M | 1.82M | 2.15M | 1.91M | 1.94M | 519.65K | 518.48K | 439.23K | 560.86K |
Other Current Assets | 5.53M | 1.66M | 1.65M | 1.27M | 1.03M | 816.21K | 751.88K | 715.8K | 71.74K | 802.21K | 797.76K | 788.92K | 1.5M | 2.14M | 1.92M | 1.44M | 1.41M |
Total Current Assets | 14.47M | 7.29M | 10.72M | 13.98M | 17.9M | 20.39M | 24.43M | 13.15M | 13.9M | 14.67M | 18.77M | 22.85M | 26.84M | 30.54M | 13.35M | 16.23M | 23.96M |
Property-Plant & Equipment | n/a | 136.68K | 143.75K | 177.59K | 216.97K | 255.22K | 292.36K | 328.46K | 363.54K | 397.65K | 430.81K | 463.07K | 494.44K | 524.95K | 554.65K | 583.56K | 611.44K |
Goodwill & Intangibles | n/a | 3.2M | 6.83M | 7.54M | 8.26M | 8.97M | 9.77M | 10.6M | 11.42M | 12.24M | 13.16M | 22.18M | 23.73M | 25.29M | 26.98M | 28.71M | 30.43M |
Total Long-Term Assets | 3.14M | 3.34M | 9.97M | 11.19M | 12.41M | 13.41M | 14.48M | 15.58M | 16.67M | 17.75M | 18.92M | 28.2M | 29.03M | 36.85M | 38.68M | 40.44M | 42.19M |
Total Assets | 17.61M | 10.64M | 20.69M | 25.17M | 30.31M | 33.8M | 38.91M | 28.73M | 30.57M | 32.42M | 37.7M | 51.05M | 55.86M | 67.39M | 52.04M | 56.67M | 66.15M |
Account Payables | 756.7K | 2.33M | 1.6M | 791.09K | 2.14M | 1.71M | 1.36M | 1.78M | 1.86M | 1.81M | 1.95M | 1.9M | 3.7M | 4.56M | 5.31M | 2.6M | 5.28M |
Deferred Revenue | n/a | 1.91M | 1.74M | n/a | 840.35K | 2.05M | 1.37M | 4.78M | n/a | n/a | 4.48M | n/a | n/a | -7.15B | 25.8M | 27.97M | 29.59M |
Short-Term Debt | n/a | 7.25M | 2.33M | 1.94M | 1.55M | 1.16M | 1.14M | 1.12M | 1.11M | 1.09M | 906.09K | 904.84K | 723.98K | n/a | 1.74M | 3.43M | 5.06M |
Other Current Liabilities | 26.38M | 8.39M | 854.76K | 5.3M | 4.93M | 1.03M | 3.05M | 2.71M | 2.38M | 822.39K | 3.94M | 3.52M | 4.12M | 22.93M | 22.71M | 25.08M | 26.12M |
Total Current Liabilities | 27.13M | 18.03M | 12.56M | 9.98M | 11.22M | 10.77M | 8.08M | 7.97M | 6.89M | 7.07M | 7.94M | 7.38M | 10.29M | 30.98M | 33.5M | 34.49M | 40.22M |
Long-Term Debt | n/a | n/a | 4.92M | 5.7M | 6.46M | 6.86M | 7.25M | 7.63M | 8.01M | 8.39M | 8.76M | 9.12M | 9.48M | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | 57.59K | n/a | 91.83K | 202K | 1.94M | 3.55M | 16.38M | n/a | n/a | n/a | n/a | n/a | n/a | 460K | 250K | 2.69M | 5.01M |
Total Long-Term Liabilities | 57.59K | 75.22K | 5.01M | 6.01M | 8.4M | 10.55M | 23.78M | 7.82M | 8.24M | 8.65M | 9.06M | 9.46M | 9.85M | 865.02K | 687.75K | 2.69M | 5.01M |
Total Liabilities | 27.19M | 18.1M | 17.58M | 15.98M | 19.62M | 21.32M | 31.86M | 15.78M | 15.12M | 15.72M | 17M | 16.83M | 20.14M | 31.85M | 34.19M | 37.18M | 45.23M |
Total Debt | n/a | 7.39M | 7.25M | 7.63M | 8.01M | 8.28M | 8.69M | 8.94M | 9.34M | 9.88M | 9.96M | 10.36M | 10.57M | 405.02K | 2.18M | 3.43M | 5.06M |
Common Stock | 205.00 | 1.05K | 1M | 930.00 | 688.00 | 298.00 | 211.00 | 211.00 | 209.00 | 208.00 | 2.07K | 2.07K | 2.07K | 2.07K | 983.00 | 983.00 | 980.00 |
Retained Earnings | -115.47M | -113.21M | -103.93M | -101.71M | -101.05M | -98.89M | -99.21M | -94.66M | -92.11M | -90.73M | -86.51M | -72.67M | -70.86M | -70.69M | -62.5M | -60.81M | -58.69M |
Comprehensive Income | n/a | n/a | n/a | n/a | -906.98K | n/a | -124.53K | 0.00 | n/a | n/a | n/a | n/a | n/a | 0.00 | 0.00 | -0.00 | 0.00 |
Shareholders Equity | -9.58M | -7.47M | 3.12M | 9.19M | 10.69M | 12.48M | 6.93M | 12.94M | 15.45M | 16.7M | 20.69M | 34.22M | 35.73M | 35.54M | 17.85M | 19.49M | 20.92M |
Total Investments | n/a | n/a | -3.89B | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |